Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université Laval

$42,000.00

The mechanisms of nitric oxyde synthesis by nitric oxide synthases

FY 2011-12

Summary
Nitric oxide synthases (NOSs) synthesize the signaling and oxidative stress molecule nitric oxide (NO). The long-term objectives of this research program are to determine the structural, functional and dynamic properties of the active site of NOSs to understand the catalytic cycle and mechanisms of regulation of the enzymatic activity at the molecular level. The NO synthesized by NOSs is used as a signaling molecule in the vascular and neural systems. It is also a toxic molecule used by the immune system in host defenses against pathogens and cancer cells. The involvement of NO in many aspects of human physiology and diseases, including atherosclerosis, Alzheimer's and Parkinson's, means that isoform-specific inhibitors are needed to regulate neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS). We expect that gaining a thorough understanding of the catalytic mechanisms of NOSs, including providing a detailed picture of heme-ligand substrate interactions and identifying key kinetic intermediates, will improve our comprehension of the chemistry of NOSs and, in the long term, will help in the development of potent, isoform-specific inhibitors of human NOSs. The specific objectives of this proposal thus are: A-Characterize by resonance Raman spectroscopy the first oxygenated intermediate formed during the catalytic cycle of NOSs using non-natural substrates and characterize the oxygenated complex of active site mutants. These studies will help determine the importance in the catalytic cycle of polar and steric interactions between substrates and the heme-bound dioxygen at the active site and will also help decipher the role played by the proximal cysteine ligated to the heme. B- Characterize the oxygenated form of NOS mutants to determine the involvement of protein dynamics in the catalytic cycle. C-Characterize catalytic intermediates formed by the reaction with peroxide. The latter two studies aim to get a better understanding of the mechanisms of NOS synthesis by NOSs. D-Characterize the interactions between heme-bound ligands (O2, NO and CO) and NOS inhibitors with all three mammalian NOSs to decipher the structural basis for inhibitor binding and isoform specificity. Together, these studies will provide an understanding at the molecular level of the mechanism of NO synthesis, identify important factors modulating the enzymatic activity and identify structural determinants for isoform-specificity of NOSs.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
250073-2007
Name nom
Couture, Manon
Department département
Biochimie, de microbiologie et de bio-informatique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2007
Award amount
42000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
5
Nb partie
5
Application title
The mechanisms of nitric oxyde synthesis by nitric oxide synthases
Keyword
NSERC
Application summary
Nitric oxide synthases (NOSs) synthesize the signaling and oxidative stress molecule nitric oxide (NO). The long-term objectives of this research program are to determine the structural, functional and dynamic properties of the active site of NOSs to understand the catalytic cycle and mechanisms of regulation of the enzymatic activity at the molecular level. The NO synthesized by NOSs is used as a signaling molecule in the vascular and neural systems. It is also a toxic molecule used by the immune system in host defenses against pathogens and cancer cells. The involvement of NO in many aspects of human physiology and diseases, including atherosclerosis, Alzheimer's and Parkinson's, means that isoform-specific inhibitors are needed to regulate neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS). We expect that gaining a thorough understanding of the catalytic mechanisms of NOSs, including providing a detailed picture of heme-ligand substrate interactions and identifying key kinetic intermediates, will improve our comprehension of the chemistry of NOSs and, in the long term, will help in the development of potent, isoform-specific inhibitors of human NOSs. The specific objectives of this proposal thus are: A-Characterize by resonance Raman spectroscopy the first oxygenated intermediate formed during the catalytic cycle of NOSs using non-natural substrates and characterize the oxygenated complex of active site mutants. These studies will help determine the importance in the catalytic cycle of polar and steric interactions between substrates and the heme-bound dioxygen at the active site and will also help decipher the role played by the proximal cysteine ligated to the heme. B- Characterize the oxygenated form of NOS mutants to determine the involvement of protein dynamics in the catalytic cycle. C-Characterize catalytic intermediates formed by the reaction with peroxide. The latter two studies aim to get a better understanding of the mechanisms of NOS synthesis by NOSs. D-Characterize the interactions between heme-bound ligands (O2, NO and CO) and NOS inhibitors with all three mammalian NOSs to decipher the structural basis for inhibitor binding and isoform specificity. Together, these studies will provide an understanding at the molecular level of the mechanism of NO synthesis, identify important factors modulating the enzymatic activity and identify structural determinants for isoform-specificity of NOSs.